 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 605
H.P. 421 House of  Representatives, February 16, 2017
An Act  To Support  Evidence-based Treatment  for Opioid  Use 
Disorder
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative VACHON of Scarborough.
Cosponsored by Senator WOODSOME of York and
Representatives: COREY of  Windham, DENNO of Cumberland, FOLEY  of Wells, GATTINE 
of Westbrook, HYMANSON of  York, MALABY of Hancock, PICKETT  of Dixfield,  Senator: 
KATZ of Kennebec.

 
 Page 1 - 128LR1638(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  Appropriations and allocations.  The following appropriations and 2 
allocations are made.  3 
HEALTH AND HUMAN SERVICES, DEPARTMENT OF  4 
Office of Substance Abuse and Mental Health Services 067 9 5 
Initiative:  Provides funding in fiscal years 2017 -18 and 2018 -19 for primary care patient - 6 
centered medical homes and behavioral health providers that provide evidence -based, 7 
integrated medication -assisted treatment to patients with opioid use disorder t o cover 8 
costs of intensive, intermediate and long -term treatment, including, but not limited to, the 9 
cost of medication, screening, behavioral health treatment and office visits for 1,000 10 
uninsured patients.  11 
 12 
 13 
 14 
 15 
 16 
 
SUMMARY  17 
This bill provides funding for primary care patient -centered medical homes and 18 
behavioral health providers that provide evidence -based, integrated medication -assisted 19 
treatment to  uninsured patients with opioid use disorder to cover costs of intensive, 20 
intermediate and long -term treatment.  21 
 GENERAL FUND  2017 -18 2018 -19 
All Other  $6,663, 000 $6,663,000  
 
  
  
GENERAL FUND TOTAL  $6,663,000  $6,663,000  
